Oncimmune - An Alden Scientific Company

Oncimmune - An Alden Scientific Company

Biotechnology

Cambridge, MA
United States
Company Tagline

We understand disease through the lens of the immune system for more effective, safer treatments & better diagnosis.

Industry Category
Biotechnology
Company Description

Oncimmune - An Alden Scientific Company stands at the forefront of biotechnology, dedicated to understanding disease through the lens of the immune system. This innovative approach paves the way for more effective, safer treatments, and enhanced diagnostics. Oncimmune has developed ImmunoINSIGHTS™, a best-in-class biomarker discovery engine, providing access to the B cell repertoire and a pivotal class of biomarkers.

With one of the world’s largest antigen libraries, covering over 9000 human antigens and multi-species variants, Oncimmune profiles antibodies from various biologic samples in very low volumes. The company's high-content biological insights and analytics are powered by proprietary machine learning algorithms, models, and deep knowledge mining solutions. Operating from its primary address at One Broadway, 14th Floor, Cambridge, MA 02142, US, and with additional facilities at Otto-Hahn Straße. 15, Dortmund, 44227, DE, Oncimmune leverages Luminex xMAP® technology to advance its mission.

Oncimmune's mission is to develop innovative technologies and solutions that improve the understanding of the immune system. This leads to more effective, targeted, and safer treatments, as well as better diagnostic tools. Oncimmune is committed to working closely with clients to discover relevant and insightful biomarkers, driving advancements in the biotechnology field. We invite the manager of Oncimmune - An Alden Scientific Company to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial development.

Oncimmune - An Alden Scientific Company est à l'avant-garde de la biotechnologie, dédiée à la compréhension des maladies à travers le prisme du système immunitaire. Cette approche innovante ouvre la voie à des traitements plus efficaces et plus sûrs, ainsi qu'à des diagnostics améliorés. Oncimmune a développé ImmunoINSIGHTS™, un moteur de découverte de biomarqueurs de premier ordre, offrant un accès au répertoire des cellules B et à une classe cruciale de biomarqueurs.

Avec l'une des plus grandes bibliothèques d'antigènes au monde, couvrant plus de 9 000 antigènes humains et des variantes multi-espèces, Oncimmune profile les anticorps à partir de divers échantillons biologiques en très faibles volumes. Les informations biologiques et analytiques à fort contenu de l'entreprise sont alimentées par des algorithmes d'apprentissage automatique propriétaires, des modèles et des solutions d'exploration de connaissances approfondies. Opérant depuis son adresse principale au One Broadway, 14th Floor, Cambridge, MA 02142, US, et avec des installations supplémentaires à Otto-Hahn Straße. 15, Dortmund, 44227, DE, Oncimmune utilise la technologie Luminex xMAP® pour faire progresser sa mission.

La mission d'Oncimmune est de développer des technologies et des solutions innovantes qui améliorent la compréhension du système immunitaire. Cela conduit à des traitements plus efficaces, ciblés et plus sûrs, ainsi qu'à de meilleurs outils de diagnostic. Oncimmune s'engage à travailler en étroite collaboration avec ses clients pour découvrir des biomarqueurs pertinents et perspicaces, stimulant ainsi les progrès dans le domaine de la biotechnologie. Nous invitons le gestionnaire d'Oncimmune - An Alden Scientific Company à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer encore leur visibilité et leur développement commercial.

Key Personnel / Employees
Hans-Dieter Zucht Frederic Collin Martin Hudson Isabel Macdonald

Compare Companies Side by Side

Compare Oncimmune - An Alden Scientific Company with 3 companies in Biotechnology

4 Companies
Comparison Field
Oncimmune - An Alden Scientific Company
Oncimmune - An Alden Scie...
Main Company
Centre for Genomic Regulation (CRG)
Centre for Genomic R...
View Profile
AMPLY Discovery
AMPLY Discovery
View Profile
Founded Year
2000 2021 2012
Company Size
501-1,000 2-10 51-200
City
Cambridge, MA Barcelona, Barcelona Belfast, Northern Ireland Warsaw, Mazowieckie
Country
United States Spain United Kingdom Poland
Skills & Keywords Comparing with main company
18 Total Skills
Biotechnology Autoantibody Biomarkers ImmunoINSIGHTS Antigen Library Machine Learning Immunotherapy Diagnostics Autoantibodies Infectious disease Companion diagnostics Systemic Lupus Autoimmune Disease Lung cancer COVID-19 Bioinformatics Systemic Sclerosis Cancer Immuno oncology
10 Total 10 Unique
Unique Skills:
Basic research Biomedicine Cell Biology Epigenetics Gene Regulation Genomics +4
13 Total 2 Common 11 Unique
Match 11%
Common Skills:
Biotechnology Machine Learning
Unique Skills:
AI Animal Health Anti-infectives Biologics Drug Discovery Genomics +5
11 Total 11 Unique
Unique Skills:
arginase chitinase fibrotic diseases Immuno-oncology inflammatory diseases +5
4
Total Companies
2000
Oldest Founded
4
Countries
49
Unique Skills

Similar Companies

Other organizations in the same industry

Atila Biosystems
Biotechnology

We are committed to bringing innovative nucleic acid amplification and detection technologies to rea...

Sunnyvale, Californi...
United States
life-genetics egypt
Biotechnology
澳斯康生物Thousand Oaks Biologics Inc.
Biotechnology

More accessible, affordable biologics for humanity!

海门市, 江苏省
Genialis
Biotechnology

The RNA Biomarker Company.

Boston, MA
United States

Alternative Company Names

This company is also known as

Oncimmune - An Alden Scientific Company ओन्कोइम्यून - एल्डन साइंटिफिक कंपनी أونكوإيمون - شركة ألدن العلمية Онкиммун - Alden Scientific Company Oncimmune - Uma Empresa Científica Alden